Search Results
Search for other papers by Carla Caruso in
Google Scholar
PubMed
Search for other papers by Lila Carniglia in
Google Scholar
PubMed
Search for other papers by Daniela Durand in
Google Scholar
PubMed
Search for other papers by Teresa N Scimonelli in
Google Scholar
PubMed
Search for other papers by Mercedes Lasaga in
Google Scholar
PubMed
mechanical allodynia in a model of chronic pain in rats Bertorelli et al . (2005) Neuroprotection HS024-selective MC4R antagonist blocks NDP-MSH protective effect on cerebral ischemia Giuliani et al . (2006) Giuliani et al . (2009) MC4R antagonist
CNRS UMR 6185- Université de Caen, INSERM-Avenir “tPA in the working brain” Centre Cycéron, BP 5229, 14074 Caen cedex, France
Search for other papers by Yohann Mérot in
Google Scholar
PubMed
CNRS UMR 6185- Université de Caen, INSERM-Avenir “tPA in the working brain” Centre Cycéron, BP 5229, 14074 Caen cedex, France
Search for other papers by François Ferrière in
Google Scholar
PubMed
CNRS UMR 6185- Université de Caen, INSERM-Avenir “tPA in the working brain” Centre Cycéron, BP 5229, 14074 Caen cedex, France
Search for other papers by Edith Debroas in
Google Scholar
PubMed
CNRS UMR 6185- Université de Caen, INSERM-Avenir “tPA in the working brain” Centre Cycéron, BP 5229, 14074 Caen cedex, France
Search for other papers by Gilles Flouriot in
Google Scholar
PubMed
CNRS UMR 6185- Université de Caen, INSERM-Avenir “tPA in the working brain” Centre Cycéron, BP 5229, 14074 Caen cedex, France
Search for other papers by Dominique Duval in
Google Scholar
PubMed
CNRS UMR 6185- Université de Caen, INSERM-Avenir “tPA in the working brain” Centre Cycéron, BP 5229, 14074 Caen cedex, France
Search for other papers by Christian Saligaut in
Google Scholar
PubMed
protect control cells and cells expressing ERαCF from the oxidative shock (Fig. 4B ). Altogether, our data suggest that 17βE2 is neuroprotective and requires an ERα presenting the A/B domain. In addition, the ERα-dependent neuro-protection by 17βE2 was not
Search for other papers by Silvia Giatti in
Google Scholar
PubMed
Search for other papers by Roberto Cosimo Melcangi in
Google Scholar
PubMed
Search for other papers by Marzia Pesaresi in
Google Scholar
PubMed
P Marchand-Leroux C O’Malley BW Lydon JP 2012 Progesterone receptors: a key for neuroprotection in experimental stroke . Endocrinology 153 3747 – 3757 . ( doi:10.1210/en.2012-1138 ) Lorenz C Contardo-Jara V Trubiroha
Search for other papers by Jaume Folch in
Google Scholar
PubMed
Search for other papers by Ignacio Pedrós in
Google Scholar
PubMed
Search for other papers by Iván Patraca in
Google Scholar
PubMed
Search for other papers by Francesc Sureda in
Google Scholar
PubMed
Unitat de Farmacologia i Farmacognòsia, Unitats de Bioquímica i Farmacologia, Departament de Biologia Cel.lular, División de Neurociencias, Facultat de Farmàcia, Institut de Biomedicina (IBUB), Centros de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), Universitat de Barcelona, Nucli Universitari de Pedralbes, 08028 Barcelona, Spain
Search for other papers by Fèlix Junyent in
Google Scholar
PubMed
Search for other papers by Carlos Beas-Zarate in
Google Scholar
PubMed
Search for other papers by Ester Verdaguer in
Google Scholar
PubMed
Search for other papers by Mercè Pallàs in
Google Scholar
PubMed
Search for other papers by Carme Auladell in
Google Scholar
PubMed
Search for other papers by Antoni Camins in
Google Scholar
PubMed
-induced increase of BDNF levels may be the main potential mechanism that mediates neuroprotection and gives support to the application of Lep as a neuroprotective drug in experimental PD models. Lep and epilepsy The interest in Lep as anti-epileptogenic therapy has
Search for other papers by Alessandro Peri in
Google Scholar
PubMed
Search for other papers by Mario Serio in
Google Scholar
PubMed
, and die within a few hours ( Mirza et al . 2006 , 2008 ). Seladin-1 as a new effector of estrogen receptor (ER)-mediated neuroprotection There is well established in vitro evidence that estrogens exert neurotropic and neuroprotective effects by
Search for other papers by María Angeles Arevalo in
Google Scholar
PubMed
Search for other papers by María Santos-Galindo in
Google Scholar
PubMed
Search for other papers by Natalia Lagunas in
Google Scholar
PubMed
Search for other papers by Iñigo Azcoitia in
Google Scholar
PubMed
Search for other papers by Luis M Garcia-Segura in
Google Scholar
PubMed
schizophrenia ( Kulkarni et al . 2010 ). SERMs and neuroprotection: a summary of the findings We can conclude that the studies conducted so far to evaluate the neuroprotective activity of tamoxifen and raloxifene indicate that these SERMs decrease neuronal
Search for other papers by Susanne Arnold in
Google Scholar
PubMed
Search for other papers by Gilda Wright de Araújo in
Google Scholar
PubMed
Search for other papers by Cordian Beyer in
Google Scholar
PubMed
CNS ( Pellerin et al . 2007 , Schousboe et al . 2007 ). They are implicated in the regulation of growth, cell proliferation, and neuroprotection in the brain ( Beyer 1999 , Beyer et al . 2003 , Garcia-Segura et al . 2003 , Kajta & Beyer 2003
Dipartimento di Scienze Farmacologiche e Biomolecolari, Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Milano, Italy
Search for other papers by Silvia Giatti in
Google Scholar
PubMed
Search for other papers by Mariaserena Boraso in
Google Scholar
PubMed
Dipartimento di Scienze Farmacologiche e Biomolecolari, Center of Excellence on Neurodegenerative Diseases, Università degli Studi di Milano, Milano, Italy
Search for other papers by Roberto Cosimo Melcangi in
Google Scholar
PubMed
Search for other papers by Barbara Viviani in
Google Scholar
PubMed
be inhibited, but at the same time the inflammatory pathways that lead to neuroprotection will not be preserved. A possible approach to control neuroinflammation could consist of the restoration of the feedback mechanisms that enable the brain to
Department of Internal Medicine, Jacobi Medical Center, Bronx, New York, USA
Search for other papers by Sriram Gubbi in
Google Scholar
PubMed
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA
Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
Search for other papers by Gabriela Farias Quipildor in
Google Scholar
PubMed
Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
Division of Geriatrics, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
Department of Genetics, Albert Einstein College of Medicine, Bronx, New York, USA
Search for other papers by Nir Barzilai in
Google Scholar
PubMed
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA
Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
Search for other papers by Derek M Huffman in
Google Scholar
PubMed
Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
Division of Geriatrics, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
Search for other papers by Sofiya Milman in
Google Scholar
PubMed
effects of both estrogen and IGF1, suggesting that the neuroprotective effect of estrogen may be mediated via IGF1 signaling. In summary, both central and peripheral administrations of IGF1 have resulted in neuroprotection in animal PD models. However
BioPharmaNet-DIMORFIPA, National Institute of Biostructures and Biosystems, University of Bologna, Via Tolara di Sopra 50, 40064 Ozzano Emilia, Bologna, Italy
Search for other papers by Laura Calzà in
Google Scholar
PubMed
Search for other papers by Mercedes Fernandez in
Google Scholar
PubMed
BioPharmaNet-DIMORFIPA, National Institute of Biostructures and Biosystems, University of Bologna, Via Tolara di Sopra 50, 40064 Ozzano Emilia, Bologna, Italy
Search for other papers by Luciana Giardino in
Google Scholar
PubMed
/or neuroprotection through endogenous stem and precursor cells are currently under active investigation, also in view of safety issues. This short review deals with the latter approach, focusing on multiple sclerosis (MS), i.e. the most diffuse demyelinating disease